Mayer Davidson to Treatment Outcome
This is a "connection" page, showing publications Mayer Davidson has written about Treatment Outcome.
Connection Strength
0.374
-
Hsia SH, Navar MD, Duran P, Shaheen M, Davidson MB. Sitagliptin compared with thiazolidinediones as a third-line oral antihyperglycemic agent in type 2 diabetes mellitus. Endocr Pract. 2011 Sep-Oct; 17(5):691-8.
Score: 0.076
-
Davidson MB, Ansari A, Karlan VJ. Effect of a nurse-directed diabetes disease management program on urgent care/emergency room visits and hospitalizations in a minority population. Diabetes Care. 2007 Feb; 30(2):224-7.
Score: 0.056
-
Ballani P, Tran MT, Navar MD, Davidson MB. Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients. Diabetes Care. 2006 Nov; 29(11):2504-5.
Score: 0.055
-
Davidson MB. SF-36 and diabetes outcome measures. Diabetes Care. 2005 Jun; 28(6):1536-7.
Score: 0.050
-
Hsia SH, Bazargan M, Davidson MB. Effect of Pancreas Tonic (an ayurvedic herbal supplement) in type 2 diabetes mellitus. Metabolism. 2004 Sep; 53(9):1166-73.
Score: 0.047
-
Davidson MB. Triple therapy: definitions, application, and treating to target. Diabetes Care. 2004 Jul; 27(7):1834-5.
Score: 0.047
-
Davidson MB. Effect of nurse-directed diabetes care in a minority population. Diabetes Care. 2003 Aug; 26(8):2281-7.
Score: 0.044